Gankyrin: an intriguing name for a novel regulator of p53 and RB

Guillermina Lozano1, Gerard P Zambetti

  • 1The University of Texas M.D. Anderson Cancer Center, Department of Molecular Genetics, Section of Cancer Genetics, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Cancer Cell
|July 19, 2005
PubMed

Insights

Gankyrin, a protein overexpressed in liver cancer, promotes tumor development by targeting both RB and p53 tumor suppressors. This dual action makes gankyrin a promising therapeutic target for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • RB and p53 are critical tumor suppressors, and their inactivation is crucial for cancer development.
  • Gankyrin is a 26S proteasome component overexpressed in liver cancer, known to bind RB and promote cell transformation.

Purpose of the Study:

  • To investigate the role of gankyrin in the p53 pathway.
  • To elucidate the dual function of gankyrin as a negative regulator of both RB and p53.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Western blotting to analyze protein levels and degradation.
  • Cellular transformation assays.

Main Results:

  • Gankyrin binds to MDM2, a key regulator of p53.
  • Gankyrin facilitates MDM2-mediated degradation of p53.
  • Gankyrin acts as a dual inhibitor of both RB and p53 pathways.

Conclusions:

  • Gankyrin is implicated as a dual-purpose negative regulator of RB and p53 tumor suppressors.
  • These findings identify gankyrin as a potential therapeutic target for liver cancer and other malignancies involving RB/p53 pathway alterations.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...